Pfizer Wants to Make Vaccine in India if Faster Clearance, Export Freedom Assured: Report

[ad_1]

Read More/Less


Pfizer Inc has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.

The U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany’s BioNTech SE, out of one of the world’s biggest drug markets.

Pfizer was the first company to apply for emergency use authorisation in India, proposing to import doses from its U.S. and European facilities instead of producing locally.

“U.S. companies want to produce vaccines in India under joint ventures,” said one of the sources, citing Pfizer and fellow U.S. drugmaker Moderna Inc.

“They want faster approvals for clinical trials and emergency authorisation use. They fear the government will introduce price control policies.”

Another source confirmed Pfizer was interested in manufacturing in India but Reuters could not find a second confirmation on Moderna.

The companies did not immediately respond to requests for comment. India’s health ministry directed Reuters to the foreign ministry, which did not immediately respond to emailed queries.

While withdrawing its application in early February, Pfizer said it would again seek emergency use approval to launch its COVID-19 vaccine in India, potentially a market of 1.35 billion people, and would provide more data as it becomes available.

On the government’s demand to manufacture in India, the company earlier told Reuters: “Once the pandemic supply phase is over and we enter a phase of regular supplies, Pfizer will evaluate all additional opportunities available.”

A Indian official told Reuters in January the government had held discussions with Pfizer and Moderna – both of which have reported more than 90% efficacy for their vaccines – to make the shots in India given its large pharmaceuticals capacity.

The Serum Institute of India, the world’s largest vaccine maker, is already bulk-manufacturing the Oxford University/AstraZeneca product and plans to start producing the Novavax Inc shot from next month.

India’s government has not allowed it to sell on the higher-priced private market, however, and is also controlling exports. Pfizer and Moderna, whose shots are more expensive than the AstraZeneca one being used in India’s immunisation campaign, are not comfortable with strict price and export restrictions, one of the sources said.

This week, Reuters reported that leaders of the Quad alliance  Australia, Japan, India, and the United States plan to announce financing agreements to increase India’s vaccine manufacturing capacity at their first meeting on Friday.

The initiative will mainly involve the production of the Novavax and Johnson & Johnson shots for supplying to regions including Southeast Asia, where their common rival China is making gains.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | Ranbir Kapoor tests positive for COVID-19

[ad_1]

Read More/Less


The Bollywood star’s mother, actor Neetu Kapoor, revealed the news on social media

Actor Ranbir Kapoor has tested positive for COVID-19 and is under self quarantine, his actor-mother Neetu Kapoor said on Tuesday.

In an Instagram post, the veteran actor said Ranbir was recovering well.

Also Read | Get ‘First Day First Show’, our weekly newsletter from the world of cinema, in your inbox. You can subscribe for free here

“Thank you for your concern and your good wishes Ranbir has tested positive for COVID-19. He is on medication and recovering well. He is in self quarantine at home and following all precautions,” she wrote.

Last month, Ranbir, 38, was shooting for his upcoming film “Brahmastra” along with co-star Alia Bhatt.

Neetu, 62, had also tested positive for COVID-19 last year while shooting for her film “Jug Jugg Jeeyo” in Chandigarh.

The number of COVID-19 cases in Mumbai increased by over 1,000 for the sixth consecutive day on Monday, taking its tally to 3,34,572, an official said.

[ad_2]

READ FULL ARTICLE HERE

Japan to stage Tokyo Olympics without foreign spectators: Report | Tokyo Olympics News – Times of India

[ad_1]

Read More/Less


TOKYO: Japan‘s government has decided to stage this summer’s Tokyo Olympics and Paralympics without overseas spectators due to concern among the Japanese public about COVID-19, Kyodo news agency said on Tuesday, citing officials with knowledge of the matter.
Kyodo said the government had concluded that welcoming fans from abroad would not be possible given public concern about the coronavirus and the detection of more contagious variants in many countries, Kyodo citied the officials as saying.

[ad_2]

READ FULL ARTICLE HERE

Covaxin Phase-2 trials show vaccine safe, induces immune response, says Lancet study

[ad_1]

Read More/Less


The vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the Phase-1 trial

India’s first indigenous vaccine against COVID-19, Covaxin, is safe and generates immune response without any serious side effects, according to the interim results of the Phase-2 trials published in The Lancet Infectious Diseases journal.

The authors of the study noted that the Phase-2 results did not asses the efficacy of the vaccine codenamed BBV152.

Developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune, the vaccine has been granted emergency use authorisation in clinical trial mode by the Indian government.

Covaxin had initially raised concerns among experts over its emergency approval by India’s drug regulator.

 

The latest study comes a week after Bharat Biotech announced that the vaccine has shown 81% efficacy in the third phase of clinical trials, the results of which are yet to be published.

The Phase-2 trial to evaluate the immunogenicity and safety of BBV152 vaccine was conducted in healthy adults and adolescents aged 12-65 years at nine hospitals across nine states in India. Two intramuscular doses of vaccine were administered on day 0 and day 28.

The primary outcome was assessed in all participants who had received both doses of the vaccine. Safety was assessed in participants who received at least one dose of the vaccine.

Between September 5 and 12, last year, 921 potential participants were screened, 380 of whom were enrolled.

In the Phase-1 trial, published in the same journal last month, BBV152 induced high neutralising antibody responses that remained elevated in all participants three months after the second vaccination.

In the Phase-2 trial, BBV152 showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses — two main mechanisms within the adaptive immune system — compared with the Phase-1 trial.

Adaptive immunity occurs after exposure to an antigen either from a pathogen or a vaccination.

Reactogenicity refers to the property of a vaccine of being able to produce common, adverse reactions, especially excessive immunological responses and associated signs and symptoms, including fever and sore arm at the injection site.

Covaxin is an inactivated vaccine developed by chemically treating novel coronavirus samples to make them incapable of reproduction. This process leaves the viral proteins, including the spike protein of the coronavirus, which it uses to enter the human cells, intact.

Given as two doses, three weeks apart, the viral proteins in the vaccine activate the immune system and prepare people for future infections with the actual infectious virus.

“The results reported in this study do not permit efficacy assessments. The evaluation of safety outcomes requires extensive Phase-3 clinical trials,” the authors of the study said. “We were unable to assess other immune responses in convalescent serum samples due to the low quantity.”

Even though direct comparisons between the Phase-1 and Phase-2 trials cannot be made, the reactogenicity assessments reported in this study were substantially better in the Phase-2 trial than the Phase-1 trial and other trials with a placebo group, according to the authors.

Also, the proportion of participants reporting adverse events in the Phase-2 trial were lower than in the Phase-1 trial, they noted. “This study enrolled a small number of participants aged 12–18 years and 55–65 years. Follow-on studies are required to establish immunogenicity in children and in those aged 65 years and older,” the authors added.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

olympics torch relay: Fans likely to be barred from Olympic torch relay start: Report | Tokyo Olympics News – Times of India

[ad_1]

Read More/Less


TOKYO: The starting ceremony for this month’s Olympic torch relay will likely be held without spectators, a Japanese newspaper reported Tuesday, but fans will still be able to line the route.
The Yomiuri Shimbun daily reported that organisers fear crowding at the March 25 event in Fukushima, and will probably bar the 3,000 spectators initially planned.
Tokyo 2020 organisers did not immediately respond to a request for comment on the report, which cited an unnamed source.
The organisers have already laid out strict rules for the virus-delayed, nationwide relay, which was called off in 2020 after the historic decision to postpone the Games by a year.
Cheering along the relay route will be strictly banned, and people are asked to only attend sections near their homes and avoid crowding.
Mask-wearing will be mandatory, and spectators are asked to offer “support with applause and by using distributed goods rather than shouting or cheering”.
Portions of the relay could also be suspended if there is overcrowding.
Organisers are battling persistent doubts about whether the Games can be held safely this summer and have unveiled a rulebook with various virus countermeasures.
They are set to decide this month on whether foreign fans will be able to attend, with limits on overall spectator numbers to be set next month.

[ad_2]

READ FULL ARTICLE HERE

India at Forefront in Fighting Covid-19, Stands Out in Vaccine Policy: Gita Gopinath

[ad_1]

Read More/Less


India has been at the forefront in fighting the coronavirus pandemic and “really stands out in terms of its vaccine policy, Chief Economist of the IMF Gita Gopinath said on Monday, as she hailed the country for playing a very important role during the crisis by manufacturing and shipping the COVID-19 vaccines to several nations. Gopinath made the comments in an interactive session during the Inaugural Dr. Hansa Mehta Lecture organised on occasion of International Women’s Day.

“I also want to mention that India really stands out in terms of its vaccine policy. If you look at where exactly is one manufacturing hub for vaccines in the world – that will be India,” Gopinath said. Gopinath lauded the Serum Institute of India, saying it produces the most number of vaccines in the world in a regular year and has been manufacturing the COVID-19 vaccine doses that are delivered to COVAX and then distributed to countries around the world.

“India has been at the forefront in fighting this pandemic,” she said, noting that India has been providing vaccines through grants to several of its neighbour countries, including Bangladesh, Nepal and Myanmar, and through commercial arrangements as well. The country has been playing a very important role in helping the world in the global health crisis through its vaccination policies, she said.

Gopinath was responding to a question on India, which is a vaccine hub of the world, and the role the country can play in contributing to global economic recovery. Gopinath pointed out that India makes up about 7 per cent of world GDP based on purchasing power parity terms.

“So when you’re that large, what happens in India has implications for many other countries in the world, especially countries in the region,” she said. Noting that India was hit very hard by this pandemic, Gopinath said the country, which typically grows at over 6 per cent, recorded a growth of negative 8 per cent in 2020.

“So it was very hard hit but you do see the recovery coming back as the country has reopened, activities returning,” she said. The International Monetary Fund (IMF) has projected an impressive 11.5 per cent growth rate for India in 2021, making the country the only major economy of the world to register a double-digit growth this year amidst the coronavirus pandemic.

“Now because of its size, when you have India growing, it increases demand for goods from other parts of the world and that’s a big positive,” she said. Gopinath gave the keynote address at the Inaugural Dr. Hansa Mehta Lecture.

The lecture, named in the memory of the pioneering Indian reformer and educator, was organised virtually by India’s Permanent Mission to the UN and The United Nations Academic Impact. Mehta had served as the Indian delegate to the UN Commission on Human Rights from 1947 to 1948 and is widely known for ensuring a more gender sensitive language in the landmark Universal Declaration of Human Rights, the UDHR. She is credited with making a significant change in the language of Article 1 of the UDHR, by replacing the phrase All men are born free and equal to All human beings are born free and equal.

Speaking at the lecture, Assistant-Secretary-General & Deputy Executive Director of UN Women Anita Bhatia described Mehta as an exceptional leader who was willing to take personal and professional risks, had the ability to speak truth to power, had the courage of her convictions and most importantly, someone who had a simple and yet very powerful belief in the need for social, economic, and political justice for women. Bhatia said she would tell Mehta today that there have been huge improvements in many areas of gender equality since her time. Mehta would be astonished to learn that in many parts of the world there are now more women than men in higher education, she would be pleased at the improvements in educational opportunities and be very happy to know about the improvements in maternal mortality, in health outcomes for women generally, Bhatia said.

Bhatia said “Mehta would be astonished to learn how far we have to go given that 25 per cent of parliamentarians in the world only are women, only 14 countries in the world have gender equal cabinets, less than 10 per cent of heads of state are women and less than 10 per cent of heads of government are women. As we think ahead to what International Women’s Day symbolises and how we can build back after the crippling effects of the pandemic,” which have decimated women’s health, security, income, reducing female labour force participation, Bhatia said nations must commit to putting women at the center of efforts to build back better, paying attention to the child care burden, ensuring they really work towards the Sustainable Development Goal 5 by making women’s rights, gender equality and women’s empowerment a universal agenda for both men and boys and making gender, and women’s economic empowerment everybody’s business.

“If we are to achieve gender equality and women’s economic empowerment, we need to do so not just with women in mind, but women in the room and women at the table,” Bhatia said. Under-Secretary-General Melissa Fleming, head of global communications for the United Nations, said Mehta built an enormously rich legacy during her life as a scholar, educator, feminist, social reformer and writer and is an indispensable figure to the history of the United Nations.

[ad_2]

READ FULL ARTICLE HERE

Some coronavirus mutations may help it evade immune system’s T-killer cells: study

[ad_1]

Read More/Less


The researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed the mutations

Some mutations in the novel coronavirus may not only enable it to evade antibodies, but also make the virus unrecognisable to the immune system’s T-killer cells, says a new study which could aid in the further development of vaccines.

While antibodies dock directly onto viruses to neutralise them, the scientists, including those from the Medical University of Vienna in Austria, said the T-killer cells recognise viral protein fragments on infected cells and subsequently kill them to stop virus production.

In the current study, published in the journal Cell Immunology, the researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.

These are regions on the virus recognised by the body’s T cells.

“Our results show that many mutations in SARS-CoV-2 are indeed capable of doing this,” said study co-author Andreas Bergthaler. “With the help of bioinformatic and biochemical investigations as well as laboratory experiments with blood cells from COVID-19 patients, we were able to show that mutated viruses can no longer be recognized by T-killer cells in these regions.”

According to the researchers, there are several epitopes available for recognition by T-killer cells in most natural infections, and if the virus mutates in one place, other sites on its surface may still indicate its presence to T cells.

They said the spike protein of the virus, which it uses to enter cells and against which most vaccines are targeted, has, on average, one to six of these T cell epitopes.

“If the virus mutates in one of these regions, the risk that the infected cells will not be recognized by the T-killer cells increases,” explained Johannes Huppa, another co-author of the study.

“Especially for the further development of vaccines, we therefore have to keep a close eye on how the virus mutates and which mutations prevail globally. Currently, we see few indications that mutations in T killer cell epitopes are increasingly spreading,” added Judith Aberle, another of the study’s co-authors from the Medical University of Vienna.

The scientists believe the findings provide important insights on how the novel coronavirus interacts with the immune system.

“Furthermore, this knowledge helps to develop more effective vaccines with the potential to activate as many T-killer cells as possible via a variety of epitopes,” the scientists said. “The goal is vaccines that trigger neutralizing antibody and T killer cell responses for the broadest possible protection.”

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Universal Basic Income is the ‘vaccine’ for poverty, says researcher Scott Santens – Times of India

[ad_1]

Read More/Less


Scott Santens is a US-based researcher and writer who calls himself a “full-time advocate of unconditional basic income.” His work has been featured on World Economic Forum, Politico, The Huffington Post and many other platforms. In a conversation with TOI, Santens tells us about the history of the idea, why it is better than targeted income approach and his own experience of living with a basic income.
For many Universal Basic Income is a new idea that has just made its way to the mainstream. However, it isn’t so. Could you tell us a bit about the history of the idea?
Yes, it’s not new. We can go all the way back to Thomas More. In the US, Thomas Paine [in late 1700s] had a plan where every American would have received a large cash grant at the age of 21. And that would have been considered natural inheritance, and it would be funded by a tax on people’s inheritance.
The first real, fully universal, monthly cash kind of plan was, I think, proposed in 1918, by a couple of Quakers.
And then when we got into the ’60s and ’70s, that was when the idea of guaranteeing an income really spiked setting in the US and elsewhere, too.
That was when Martin Luther King Jr was talking about it. And Milton Friedman [Nobel-winning economist] also was talking about this, he called it a negative income tax.
[Richard] Nixon proposed a negative income tax for families in 1969, and it passed the House of Representatives in 1771. It did not make it through the Senate.
So after the ’70s, it [UBI] just kind of died off. People really started talking about it again, after the 2008 Great Recession. Everyone was talking about inequality and solutions to this inequality crisis

And then a couple years after that Europe did their first EU-wide signature initiative for universal basic income. And that requires a certain amount of signatures from each nation in the EU. So people started learning about UBI, really, for the first time in Europe.
The signature initiative did not succeed, But it still took the idea to a lot of people who would not have otherwise known about this. And then that led to Switzerland’s referendum which started the global discussion on a much bigger level.
Even though Switzerland rejected the idea, in the process again, many people all over the world learned about it.
I’m curious about your journey into UBI advocacy. How did that come about?
In 2013, a discussion hit the front page of Reddit where they were talking about how quickly technology is advancing and no one’s talking about it.
So in that discussion thread I learned things that I didn’t know already about the state of automation.
And there was a book that was recommended by a bunch of people in that thread called ‘Manna’, by Marshall Brain.
There’s this AI [in the book] that works on automating things that can be easily replaced. So he replaces the middle management.

Someone gets fired from their job by this software, because it has determined that, let’s say, they’re late to work three times in a row and it’s a three strikes out kind of thing. So then the software is also utilized by all these other companies to do their hiring. It’s not not just hiring, it’s doing the firing.
So then why would you hire this person that you already fired somewhere else? So as you’re also automating, you’re making people non-hireable. And so what do you do with them? Well, according to our current logic, you just make sure that they have food and housing and that’s it. So you can imagine these big compounds full of people who are just unemployable.
And and so the other part of the book is saying, well, you know, let’s imagine that we actually utilise technology for the benefit of everybody. It’s like more of a Star Trek kind of take. If there’s abundance through technology, then let’s make sure that everyone has access to that abundance.
So how do we make technology benefit everybody? The author’s take was that you start with a high basic income. You make sure you have that floor, so that the revenue from all the automation is flowing to everybody as an absolute minimum. They can still earn more on top of that. if you can’t find a job, you’ve got that floor, but you’ve also got the floor to create your own job to go between jobs or to work less instead.
So putting all the philosophies and studies together, it just painted a very clear picture to me that that UBI is something that would just have a really huge positive difference as far as going from dystopia to utopia. And that’s what I’d much prefer (laughs).
You say you have also crowdfunded your own basic income. How has that experience been for you?
I started that in 2014. It took all of 2015 to increase my crowdfund from the 0 to $1,000 per month, and then starting in 2016, started [getting] over $1,000 every month. And so now I’ve, I’ve been living with a basic income since 2016.
And thanks to that floor, I’m able to actually do the work that I want to do. And that’s largely writing, researching and doing podcasts, and just doing everything I can, to build this movement.
The thing I learnt that I thought was profound, right off the bat was that I started to feel a difference. Even when I just had like, $300 per month. It’s really just enough to make sure that your food is covered. I think that there was a sense of security from it that I hadn’t really felt before. Just knowing that it’s going to be there next month really takes the edge off.
The power of it is through like that unconditionality – that it’s going to be there.
That creates this sense of security, that reduces stress and, and enables you to I guess think better.
And I’d read arguments, you know, as security being, like, a big reason why UBI is the most important, but didn’t really understand it and didn’t really feel that argument until I felt security afterwards.
Another thing that I’ve learned from it, is that I really have this self-directed time. I can do what I feel is important. And, because of that I can refuse things that I feel are not important. And I can also refuse, say, you know, payments that I feel are too low.
If someone wants me to write something for them, earlier I would have accepted $50. But now, if I’m gonna spend that kind of time and research to write something, I don’t think that’s enough. And so I feel comfortable saying I’m not going to do it for $50. I’ll do it for $500 or something.
And then they can either accept it, or it won’t be written, or also decide to do it for free.
I’ve learnt that I’m actually much happier writing things for free and putting it out there with no paywall, and everyone can read it and they can even reprint it and translate it and share it. I don’t care about earning income from it, because I have my income that’s guaranteed.
So, other than the security factor that you mentioned, what have been the other key findings in your research?
There’s so many things… I would say like, first of all, is health.
You can see that a lot of what we treat medically, is actually like a lack of income when it was needed, and like a lack of stability and a lack of security. So you know, people are living with chronic stress and living with poverty, and then we end up treating it on the back end.
So if you make sure that people have enough income to not live in poverty, that you make sure that the income is stable, so that people aren’t stressed out about it, that you can actually prevent a lot of this disease, for a lot cheaper. It’s so much cheaper to be spending, you know, $1,000 a month on somebody, instead of treating them years later for like, you know, millions of dollars worth heart surgeries or whatever. So that’s one big thing.
And the evidence from the Dauphin experiment was that there was an 8.5% reduction in hospitalizations. As one researcher said, ‘If we found a drug that we could put in the water that reduces hospitalizations, by 8.5%, we would absolutely do it (laughs)’. And so, basic income can be thought of as a social vaccine.
So you could vaccinate people against poverty and chronic stress insecurity in a big way and just save so much money in the healthcare system.

UBI proponents say, many businesses fail, not because the idea was bad but because people just didn’t have the money to actually be customers at the businesses.

Another thing that I see over and over again, is that there’s a big increase in self-employment and entrepreneurship.
Like big ones in Namibia, the increase was 301%. And in the India experiment, the experimental villages were three times as likely, or had three times as much entrepreneurship as the controlled villages.
There’s a lack of capital, so that people don’t have [money] even though they have these ideas to start their own businesses, And also, another part of it is that there’s risk aversion. If you fail at your business startup, then, without a basic income, you and your entire family can fall into poverty. So a lot of people aren’t taking those risks out of fear of what happens if there’s failure.
UBI takes that risk away.
And then the third part of it, too, is that so many businesses fail, not because the idea was bad. But because people just didn’t have the money to actually be customers at the businesses.
One of the people in the Namibia experiment I thought really showed this well.
With her first payment, she went out and bought a bunch of yeast and flour, and she built a makeshift oven. And she started making these little cakes for her village. And it succeeded to the point where at the end of the experiment, she was actually making, I think, like three times more than the basic income in itself, from her business. And it was because everyone in her village actually could afford to be customers, because they now had the money to be customers.
[Without UBI] there wouldn’t have been those customers in the village. So it’s unlikely that she would have succeeded to the degree that she did.
Another one that I think is big is trust that came out in the Finland experiment with basic income. One of the surprising findings was that trust increased. So trust increased in politicians, in institutions, and in overall society.
It [basic income] is a display of trust in you. The government is saying, here’s money, you can do anything you want with it, you don’t need to prove anything to me. I trust you. And in return you feel trusted. So you trust others now more than you would otherwise. And I think like part of the problem all over the world is this lack of trust
Why is the targeting approach, of setting aside benefits and money for people who need it the most, not a good enough approach for you?
As soon as you set up that [exclusionary] line you’re always going to exclude people on the other side of that line. It’s better to get and not need than to need and not get.
We’re in a pandemic, and you really want to make sure that everyone who has lost income [gets some help]. As soon as you introduce the Means test, you’re not gonna find them. And especially when that Means test is using old data.
So it just makes more sense to say, let’s not worry about varying the amount of income on the front end, let’s just worry about taxing appropriately on the back end. So instead of saying that someone earning over $100,000 shouldn’t get the income, you say, well next year, when they do taxes, those who earned over $100,000 in 2021 will see a increase in their taxes so that the income that they received is essentially clawed back from them so they’re not a net recipient of it.
And so that’s one reason for universality. But you know, another reason is, is also just the fact that you create a stronger programme when it’s universal. The more people who receive it, the more people are going to be supportive of the policy.
There’s a lot of stigma attached to poverty alleviation programmes…
Right. So that stigma will mean that people purposely don’t apply for the programme even though they should. And also, people are upset at those people for receiving it. And they treat them poorly. And then those people who are receiving it feel poor about receiving it.
Also it’s much easier politically to demonize that and say ‘these people are taking your tax money and we should end these programmes because they’re just a bunch of leeches and stuff.
Whereas if you had a fully universal programme, you just won’t see that.
With the pandemic, many were expecting that Covid would lead to a greater or a faster approval of the basic income idea but it hasn’t been the case. Why hasn’t it happened?
We’re fighting an entrenchment of belief. And it’s just that it can’t be done, instantaneously.
Even though there’s a huge new pressure because of the pandemic, it still takes time to move the ship from the direction that it’s been going. So I’m still hopeful. And, and there’s definitely improvements happening in the direction of UBI. A child allowance is going to most likely happen here in the US and that’s something I’ve been pushing for years.

Brazil passed a Basic Income law in 2004 and it could very well be the first country to have a universal basic income in the future. (Image courtesy: Getty)

At some point, there’s going to be a country that’s actually a bigger country that will do this, where it’s like, well, let’s just make it universal and monthly. They don’t have to be big, you know, it could just be $200 per month.
Another thing about why things are going slowly. It’s because so much labour in our society is done because people feel that they have to do it in order to earn income. If they don’t do it, they’ll starve. if they don’t do what people who have the money want them to do, then they will have nothing. And so something is better than nothing. So we’ll do it.
So a lack of UBI keeps prices low and keeps people coerced into labor that they wouldn’t otherwise do at prices they wouldn’t otherwise accept.
This was something that was asked in the in Switzerland debate too when it was voting on this. And I remember one of the stories that came out of this was in one of the town halls where discussion was happening on this, someone asked, “What would happen to our maid?” They were worried that their maid would start receiving the basic income and then quit being the maid. And so that was like the first concern – well, who will keep my house clean?(laughs)
Is there any particular country you think the world should keep an eye for, which you feel could give the movement for basic income a big push?
Brazil is the first and only country to have actually passed basic income. It’s actually a law as of 2004. And the small print of that law says that it needs to be executed by the executive. So the president is the one to decide to implement basic income.
Since that law has been put into place, no president has said, let’s put it into practice.
During the pandemic [President Jair] Bolsonaro did provide a lot of money to people directly. And that increased his popularity. It could lead to Brazil being among the first to do it. So, eyes on on Brazil.
Elsewhere, Spain caused a big hubbub because they decided to do a minimum income guarantee permanently as a result of the pandemic. So that’s not UBI. It is Means tested. But still, they went from not having an income guarantee to having one.
Japan is looking good, because they did a full universal amount there as again, one-offs.
Also Canada has been doing their $2,000 a month, and it’s been targeted to those who’ve lost employment during the pandemic. There’s been a lot more push among politicians there in Canada. And I am still hoping for India as well.
I think that China is always a possibility as well, because again, China can just decide to do it. You know, there’s no democracy there. So at any point, China could be like, this is gonna increase our GDP, this is going to, really help us. Instead of relying so much on other people to consume their goods, they can consume their own goods, if they just made sure that everyone had UBI.

[ad_2]

READ FULL ARTICLE HERE

Mumbai Woman Gets 1st Covid Shot as a Gift on Her 100th B’day Amid More than 1L Vaccinations in Maha

[ad_1]

Read More/Less


A Mumbai woman, who turned 100 on March 5, celebrated a special birthday at an inoculation centre. As a gift, Parvati Khedkar, born on March 5 1921, received her first shot of Covid-19 vaccine at the city’s Bandra Kurla Complex (BKC) vaccination centre on Friday.

India started nationwide coronavirus vaccine drive on 16 January. During the first phase of vaccination, the healthcare workers and frontline workers received Covid-19 doses. Since March 1, those who are above 60 years of age are getting jabbed against novel coronavirus.

Maharashtra is facing the toughest time since the beginning of the pandemic last year as the western state has been clocking the highest number of Covid-19 cases. The state on Friday registered 10,216 new infections — the highest since October 16. The state now has 90,055 active cases after touching a low of 30,265 on February 10.

The Centre has also rushed high-level multi-disciplinary public health teams to Maharashtra in view of the increase in number of daily Covid-19 cases. The high-level team to Maharashtra will be led by P Ravindran, Sr CMO, Disaster Management Cell, MOHFW. The team will visit the (Covid-19) hotspot areas in the state and ascertain reasons for the surge in cases, the health ministry said.

A record 1,13,669 people were vaccinated against Covid-19 in Maharashtra on Saturday, the first time the number of beneficiaries covered in a day crossed the 1-lakh mark, state health officials said. Of these, 93,476 received the first dose and the rest 20,193 were administered the second one, and included 62,342 people over the age of 60 and 11,241 in the 45 plus age group with comorbidities, an official release said.

“The ones who got the first dose included 10,904 health care and 8,989 frontline workers, while for the second dose, the figures were 17,225 and 2,968 respectively,” he said. The number of people vaccinated so far in the state since January 16 has reached 17,44,724.

[ad_2]

READ FULL ARTICLE HERE

Boxer Manish Kaushik strikes gold at Boxam International | Boxing News – Times of India

[ad_1]

Read More/Less


NEW DELHI: Olympic-bound Indian boxer Manish Kaushik (63kg) struck gold in his first competitive outing in a year even as five others signed off with silver medals in the 35th Boxam International Tournament in Castellon, Spain.
Manish defeated Denmark’s Nikolai Terteryan in a split decision Vikas krishan against Youba Sissokho of Spain.
However, Mohammed Hussamuddin (57kg) and Vikas Krishan (69kg) ended with silver medals among men.
Hussamuddin gave a walkover to Jean Paul Rivera of Puerto Rico, which was struck by a positive COVID-19 case. The reasons for the Indian’s pullout were not immediately not known.
Vikas Krishan (69kg), however, lost a gruelling final to Spain’s Youba Sissokho, a bout in which the Indian was left with a cut above his right eye.
Among women, Simranjit Kaur (60kg), Pooja Rani (75kg) and Jasmine (57kg) ended with silver medals among women.
World bronze-medallist Simranjit could not take the ring against Rashida Ellis of USA after her semifinal opponent Kiria Tapia of Puerto Rico positive COVID-19 report forced the organisers to stop her from competing despite the Indian returning a negative test.
“Because of local government regulations, she could not compete,” Indian women’s boxing’s high performance director Rafaelle Bergamasco told PTI from Castellon after initial information of an injury trickled in.
Pooja, on the other hand, lost 0-5 to another American Melissa Graham.
The Indian women boxers thus ended their campaign with three silver and one bronze medal. Six-time world champion M C Mary Kom (51kg) had ended with a bronze after a semifinal loss.
Debutant Jasmine (57kg) also ended with a silver after going down to European champion Irma Testa of Italy.
Asian champion Pooja fought hard but did not connect as much as she attempted against the decidedly faster Graham, who dominated with her impressive counter-attacks.
The spirited Jasmine also gave it her all but Testa’s tactical superiority shone through.
The nimble-footed Italian’s eye-catching combination punches and sheer power were just too much to handle for the rookie Indian, whose campaign overall was quite impressive.
Later on Saturday night, Ashish Kumar (75kg), Sumit Sangwan (81kg) and Satish Kumar (+91kg) will compete in the men’s finals.
Of these, Ashish and Satish are bound for the Tokyo Olympics.

[ad_2]

READ FULL ARTICLE HERE

1 7 8 9 10 11 13